News

Fougera’s Calcipotriene Topical Solution (scalp solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. It is available in a 60ml bottle. David

Peregrine presented preclinical studies demonstrating that PGN635, a fully human antibody discovered as part of their collaboration, exhibits antitumor efficacy by targeting phosphatidylserine (PS). PGN635 was isolated using

Changes in miR-181a levels have been shown to modify the response of immune cells such as T lymphocytes to specific stimuli and its antagonism could lead to a

The proceeds of this financing will be used to repay certain debentures and the existing term debt with National Bank of Canada, as well as for general working

Pursuant to the option agreement, the pre-commercial milestone payments in the amended license agreement will be reduced from $25 million to $7 million payable on or before December

A Phase II human clinical trial with the new combination therapy, consisting of DiaKine’s Lisofylline (LSF) and Kinexum’s Islet neogenesis associated protein (INGAP) peptide, is expected to begin

Clinical trial application acceptance is a key China’s State Food & Drug Administration (SFDA) requirement prior to pursuing a clinical trial and, ultimately, completing commercialization of a pharmaceutical

Prana’s drug candidates are being tested on two widely used mouse models for Parkinson’s disease, which employ either the 6-hydroxy-dopamine (6-OHDA) or MPTP toxins. These models mimic the

According to the company, Artemis’s 3D/4D imaging allows doctors to select and biopsy a location within the boundary of the prostate with pinpoint accuracy. The biopsy location is